| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Transmembrane domain-containing protein TMIGD3 |
|---|
| Ligand | BDBM50118803 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_1556380 (CHEMBL3772111) |
|---|
| IC50 | 42±n/a nM |
|---|
| Citation |  Donegan, RK; Lieberman, RL Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions. J Med Chem59:788-809 (2016) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Transmembrane domain-containing protein TMIGD3 |
|---|
| Name: | Transmembrane domain-containing protein TMIGD3 |
|---|
| Synonyms: | TMIG3_HUMAN | TMIGD3 | Transmembrane domain-containing protein TMIGD3 |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 30335.79 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_114868 |
|---|
| Residue: | 266 |
|---|
| Sequence: | MEGSPAGPIEQKEARWESSWEEQPDWTLGCLSPESQFRIPGLPGCILSFQLKVCFLPVMW
LFILLSLALISDAMVMDEKVKRSFVLDTASAICNYNAHYKNHPKYWCRGYFRDYCNIIAF
SPNSTNHVALRDTGNQLIVTMSCLTKEDTGWYWCGIQRDFARDDMDFTELIVTDDKGTLA
NDFWSGKDLSGNKTRSCKAPKVVRKADRSRTSILIICILITGLGIISVISHLTKRRRSQR
NRRVGNTLKPFSRVLTPKEMAPTEQM
|
|
|
|---|
| BDBM50118803 |
|---|
| n/a |
|---|
| Name | BDBM50118803 |
|---|
| Synonyms: | (2R,3R,4S,5S)-3,4-dihydroxy-2-[6-(3-iodo-benzylamino)-purin-9-yl]-1-oxa-7-aza-spiro[4.4]nonan-6-one | 3,4-Dihydroxy-2-[6-(3-iodo-benzylamino)-purin-9-yl]-1-oxa-7-aza-spiro[4.4]nonan-6-one | CHEMBL344187 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C19H19IN6O4 |
|---|
| Mol. Mass. | 522.2964 |
|---|
| SMILES | O[C@@H]1[C@H](O)[C@]2(CCNC2=O)O[C@H]1n1cnc2c(NCc3cccc(I)c3)ncnc12 |
|---|
| Structure | 
|
|---|
Search and Browse
